MedHexim1
MedHexim1 focuses on Hexim1 as a biomarker and drug design target as strategy to develop a diagnostic test and therapy for prostate cancer. MedHexim1 Team: Eduardo Mascareno, PhD, President Manya Dhar-Mascareno, President
Read MoreBrooklyn Biologics
Brooklyn Biologics — Our product is a novel formulation of protein and lipids, enabling in vitro/in vivo transfection with DNA/siRNA/miRNA at higher efficiency rates. Brooklyn Biologics Team: Carlo Yuvienco, PhD, Co-Founder Joseph Frezzo Jin Montclare
Read MoreMySmileBuddy
MySmileBuddy’s interactive tablet-based educational and action-planning technology supports parent/lay health worker dyads in managing risks for early childhood tooth decay consistent with current best science. MySmileBuddy Team: Burton L. Edelstein, DDS MPH, CEO Christie Custodio-Lumsden, PhD, COO
Read MoreHyperfine
Hyperfine – My company/technology is advanced analytics software for personalized medicine – the goal for my company is to assist in the creation of cures. Hyperfine Team: Bridget Osetinksy, CEO Bobby Mannepalli, COO
Read MoreZakan Theraputics
Zakan Therapeutics — A biological therapeutic that can directly attack metastatic cancer cells by delivering a payload of anti-cancer compounds while bypassing healthy cells. Zakan Theraputics Team: Arthee Jahangir Benjamin Caballero
Read MoreNovyx Technologies
A cost-effective hydrogel dressing for chronic wounds, which enhances wound healing, reduces inflammation, risk of infection and pain, as well as provides comfort during use. Novyx Technologies Team: Waleed Abdel-Naby, PhD
Read MoreTaithera, Inc.
Aithera is a revolutionary nanomedicine bone targeted drug delivery controlled release platform technology for the treatment of musculoskeletal conditions focused initially on fracture healing & bone cancer (osteosarcoma is our first oncology target). Aithera Team: Seth Harlem, CEO Mo Chen, PhD, CSO
Read MoreMassive Bio
Massive Bio provides cutting-edge concierge advisory services for precision oncology to cancer patients treated at community practices. Massive Bio Team: Selin Kurnaz, PhD. – CEO
Read MoreAision Biotechnologies
Prophylactic drugs that protect against depression and PTSD in a vaccine-like fashion. Rebecca Brachman, Co-Founder Christine Denny, PhD, Co-Founder
Read MoreJotteq
Jot is a new kind of eye drop dispenser that is safe and easy to use. My objective is to bring it to market Jotteq Team: Nigel Kelly
Read More